BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37603014)

  • 1. cGAS-STING Pathway Activation during Trypanosoma cruzi Infection Leads to Tissue-Dependent Parasite Control.
    Perumal N; White B; Sanchez-Valdez F; Tarleton RL
    J Immunol; 2023 Oct; 211(7):1123-1133. PubMed ID: 37603014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING Signaling Drives Production of Innate Cytokines, Generation of CD8
    Vieira RS; Nascimento MS; Noronha IH; Vasconcelos JRC; Benvenuti LA; Barber GN; Câmara NOS; Kalil J; Cunha-Neto E; Almeida RR
    Front Immunol; 2021; 12():775346. PubMed ID: 35095849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmonella Induces the cGAS-STING-Dependent Type I Interferon Response in Murine Macrophages by Triggering mtDNA Release.
    Xu L; Li M; Yang Y; Zhang C; Xie Z; Tang J; Shi Z; Chen S; Li G; Gu Y; Wang X; Zhang F; Wang Y; Shen X
    mBio; 2022 Jun; 13(3):e0363221. PubMed ID: 35604097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Activation of T Cells at the Site of Infection Facilitates the Establishment of Trypanosoma cruzi in Both Naive and Immune Hosts.
    Padilla AM; Rosenberg C; Cook P; Sanchez-Valdez F; McElhannon C; Tarleton RL
    mSphere; 2023 Feb; 8(1):e0060122. PubMed ID: 36695605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferons increase host susceptibility to Trypanosoma cruzi infection.
    Chessler AD; Caradonna KL; Da'dara A; Burleigh BA
    Infect Immun; 2011 May; 79(5):2112-9. PubMed ID: 21402764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
    Anghelina D; Lam E; Falck-Pedersen E
    J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic expression of cGAS in
    Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP1-cGAS-NF-κB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease.
    Choudhuri S; Garg NJ
    PLoS Pathog; 2020 Apr; 16(4):e1008474. PubMed ID: 32315358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner.
    Liang L; Shen Y; Hu Y; Liu H; Cao J
    PLoS Pathog; 2022 Feb; 18(2):e1010233. PubMed ID: 35108342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING.
    Biolatti M; Dell'Oste V; Pautasso S; Gugliesi F; von Einem J; Krapp C; Jakobsen MR; Borgogna C; Gariglio M; De Andrea M; Landolfo S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway.
    García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi.
    Koga R; Hamano S; Kuwata H; Atarashi K; Ogawa M; Hisaeda H; Yamamoto M; Akira S; Himeno K; Matsumoto M; Takeda K
    J Immunol; 2006 Nov; 177(10):7059-66. PubMed ID: 17082622
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Costa Franco MM; Marim F; Guimarães ES; Assis NRG; Cerqueira DM; Alves-Silva J; Harms J; Splitter G; Smith J; Kanneganti TD; de Queiroz NMGP; Gutman D; Barber GN; Oliveira SC
    J Immunol; 2018 Jan; 200(2):607-622. PubMed ID: 29203515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Blockade of Interleukin-2 During the Acute Phase of
    Nihei J; Cardillo F; Mengel J
    Front Cell Infect Microbiol; 2021; 11():758273. PubMed ID: 34869064
    [No Abstract]   [Full Text] [Related]  

  • 17. cGAS and Ifi204 cooperate to produce type I IFNs in response to Francisella infection.
    Storek KM; Gertsvolf NA; Ohlson MB; Monack DM
    J Immunol; 2015 Apr; 194(7):3236-45. PubMed ID: 25710914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borrelia burgdorferi Engages Mammalian Type I IFN Responses via the cGAS-STING Pathway.
    Farris LC; Torres-Odio S; Adams LG; West AP; Hyde JA
    J Immunol; 2023 Jun; 210(11):1761-1770. PubMed ID: 37067290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi triggers an early type I IFN response in vivo at the site of intradermal infection.
    Chessler AD; Unnikrishnan M; Bei AK; Daily JP; Burleigh BA
    J Immunol; 2009 Feb; 182(4):2288-96. PubMed ID: 19201883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.